American Journal of Kidney Diseases
Volume 37, Issue 5 , Pages 1011-1017 , May 2001

Identification and treatment of depression in a cohort of patients maintained on chronic peritoneal dialysis

Received 7 July 2000 ,Accepted 8 December 2000.

References 

  1. Finkelstein FO, Finkelstein SH. Psychological adaptation and quality of life of the patient with end-stage renal disease. In: Brown E, Parfrey P editor. Complications of Long Term Dialysis. London, UK: Oxford University Press; 1999;p. 168–187
  2. Levy NB. Psychology and rehabilitation. In: Daugaurdis JT, Ing TS editor. ed 2. Handbook of Dialysis. Boston, MA: Little Brown; 1994;p. 369–373
  3. De-Nour AK. Psychological, social and vocational impact of renal failure: A review. In: McGee H, Bradley C editor. Quality of Life Following Renal Failure. Chur: Harwood Academic; 1994;p. 33–42
  4. Wolcott DL, Nissenson AR, Landserk J. Quality of life in chronic dialysis patients. Gen Hosp Psychiatry. 1988;10:267–277
  5. Wuerth D, Finkelstein SH, Juergensen D, Juergensen P, Steele TE, Kliger AS, et al. Quality of life assessment in chronic peritoneal dialysis patients. Adv Perit Dial. 1997;13:125–127
  6. Juergensen PH, Wuerth DB, Juergensen DM, Finkelstein SH, Steele TE, Kliger AS, et al. Psychological factors and incidence of peritonitis. Adv Perit Dial. 1996;12:196–198
  7. Kimmel PL, Weihs K, Peterson RA. Survival in hemodialysis patients: Role of depression. J Am Soc Nephrol. 1993;4:12–27
  8. Kimmel PL, Peterson RA, Weihs KL. Multiple measurements of depression predict mortality in a longitudinal study of chronic hemodialysis patients. Kidney Int. 2000;57:2093–2098
  9. Kennedy SH, Craven JI, Roin GM. Major depression in renal dialysis patients: An open trial of antidepressant therapy. J Clin Psychiatry. 1989;50:60–63
  10. Juergensen PH, Allen JR, Kliger AS, Finkelstein FO. Adequacy of CPD: Comparing Kt/V and creatinine clearance. Adv Perit Dial. 1998;14:72–74
  11. Steele TE, Wuerth D, Finkelstein SH, Juergensen D, Juergensen P, Kliger AS, et al. Sexual experience of the chronic peritoneal dialysis patient. J Am Soc Nephrol. 1996;7:1165–1168
  12. Steele TE, Baltimore D, Finkelstein SH, Juergensen P, Kliger AS, Finkelstein FO. Quality of life in peritoneal dialysis patients. J Nerv Ment Dis. 1996;184:368–374
  13. In: McEvoy GK editors. AHFS Drug Information. Bethesda, MD: American Society of Health Systems Pharmacists; 1999;p. 1924–1932In: McEvoy GK editors. AHFS Drug Information. Bethesda, MD: American Society of Health Systems Pharmacists; 1999;p. 1946–1947In: McEvoy GK editors. AHFS Drug Information. Bethesda, MD: American Society of Health Systems Pharmacists; 1999;p. 1960–1972
  14. Ruberman W, Weinblatt E, Goldberg JD, Chaudhary BS. Psychooocial influences on mortality after myocardial infarction. N Engl J Med. 1984;311:552–559
  15. Frasure-Smith N, Temperance F, Thalamic M. Depression and 18-month survival after myocardial infarction. Circulation. 1995;91:999–1005
  16. Herrmann C, Brand-Diehards S, Kaminski B, Leaving E, Stats H, Urge U. Diagnostic groups and depressed mood as predictors of 22-month mortality in medical inpatients. Psychosom Med. 1998;60:570–577
  17. Colinsky KE, Kabana E, Chin MH, Palmer RM, Fortinsky RH, Landefeld CS. Depressive symptoms and 3-year mortality in older hospitalized patients. Ann Intern Med. 1999;130:563–569
  18. Carey H, Finkelstein SH, Santacroce S, Brennan N, Raffone D, Rifkin J, et al. The influence of age and psychosocial factors on CAPD dropout. Adv Perit Dial. 1990;6:26–28
  19. Roose SP, Laghrissi-Thode F, Kennedy JS, Nelson C, Bigger JT, Pollock BG, et al. Comparison of paroxetine and nortriptyline in depressed patients with ischemic heart disease. JAMA. 1998;279:287–291
  20. Thapa PB, Gideon P, Lust TW, Milam AB, Ray WA. Antidepressants and the risk of falls among nursing home residents. N Engl J Med. 1998;339:875–882
  21. DasGupta K. Treatment of depression in elderly patients: Recent advances. Arch Fam Med. 1998;7:274–280
  22. Small GW. Treatment of geriatric depression. Depress Anxiety. 1998;8(suppl 1):S32–S42
  23. Hay DP, Rodriguez MM, Franson KL. Treatment of depression in late life. Clin Geriatr Med. 1998;14:33–46
  24. Davidson J. Pharmacologic treatment. In: Coffey CE, Cummings JL editor. Textbook of Geriatric Psychiatry. ed 2. Washington, DC: American Psychiatric Press; 2000;p. 359–377
  25. Levy NB. Psychopharmacology in patients with renal failure. Int J Psychiatry Med. 1990–1991;20:303–312
  26. Keller MB, McCullough JP, Klein DN, Arnow B, Dunner DL, Gelenberg AJ, et al. A comparison of nefazodone, the cognitive behavioral-analysis system of psychotherapy, and their combination for the treatment of chronicdepression. N Engl J Med. 2000;342:1462–1470

PII: S0272-6386(05)80018-6

American Journal of Kidney Diseases
Volume 37, Issue 5 , Pages 1011-1017 , May 2001

Article Tools